Plasma concentrations of histidine-rich glycoprotein in primary graft dysfunction after lung transplantation

被引:0
作者
Shiotani, Toshio [1 ,2 ]
Sugimoto, Seiichiro [1 ,2 ,4 ,5 ]
Tomioka, Yasuaki [1 ,2 ]
Tanaka, Shin [1 ,2 ]
Mitsuhashi, Toshiharu [3 ]
Suzawa, Ken [1 ,2 ]
Shien, Kazuhiko [1 ,2 ]
Miyoshi, Kentaroh [1 ,2 ]
Yamamoto, Hiromasa [1 ,2 ]
Okazaki, Mikio [1 ,2 ]
Toyooka, Shinichi [1 ,2 ]
机构
[1] Okayama Univ Hosp, Dept Gen Thorac Surg, Okayama, Japan
[2] Okayama Univ Hosp, Organ Transplant Ctr, Okayama, Japan
[3] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
[4] Okayama Univ Hosp, Dept Gen Thorac Surg, 2-5-1 Shikata Cho,Kita Ku, Okayama 7008558, Japan
[5] Okayama Univ Hosp, Organ Transplant Ctr, 2-5-1 Shikata Cho,Kita Ku, Okayama 7008558, Japan
来源
INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY | 2024年 / 38卷 / 02期
基金
日本学术振兴会;
关键词
Lung transplantation; Primary graft dysfunction; Histidine-rich glycoprotein; Chronic lung allograft dysfunction; Overall survival; ISHLT WORKING GROUP; INTERNATIONAL-SOCIETY; HEART; DEFINITION; STATEMENT;
D O I
10.1093/icvts/ivae021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Histidine-rich glycoprotein has been reported as an anti-inflammatory glycoprotein that inhibits acute lung injury in mice with sepsis and as a prognostic biomarker in patients with sepsis. We investigated the relationship between plasma concentrations of histidine-rich glycoprotein and the risk of occurrence of primary graft dysfunction. METHODS: According to the primary graft dysfunction grade at post-transplant 72 h, patients who underwent lung transplantation were divided into three groups: non-primary graft dysfunction group (grade 0-1), moderate primary graft dysfunction group (grade 2), and severe primary graft dysfunction group (grade 3). The plasma concentrations of histidine-rich glycoprotein measured daily during the first post-transplant 7 days were compared among the three groups. Appropriate cutoff values of the concentrations were set for survival analyses after lung transplantation. RESULTS: A total of 68 patients were included. The plasma histidine-rich glycoprotein concentration at post-transplant 72 h was significantly lower in the severe primary graft dysfunction group (n = 7) than in the other two groups [non-primary graft dysfunction group (n = 43), P = 0.042; moderate primary graft dysfunction group (n = 18), P = 0.040]. Patients with plasma histidine-rich glycoprotein concentration >= 34.4 mu g/ml at post-transplant 72 h had significantly better chronic lung allograft dysfunction-free survival (P = 0.012) and overall survival (P = 0.037) than those with the concentration <34.4 <mu>g/ml. CONCLUSIONS: Plasma histidine-rich glycoprotein concentrations at post-transplant 72 h might be associated with the risk of development of primary graft dysfunction.
引用
收藏
页数:8
相关论文
共 50 条
[31]   Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation [J].
Hoffman, S. A. ;
Wang, L. ;
Shah, C. V. ;
Ahya, V. N. ;
Pochettino, A. ;
Olthoff, K. ;
Shaked, A. ;
Wille, K. ;
Lama, V. N. ;
Milstone, A. ;
Ware, L. B. ;
Orens, J. ;
Weinacker, A. ;
Demissie, E. ;
Bellamy, S. ;
Kawut, S. M. ;
Hancock, W. W. ;
Christie, J. D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (02) :389-396
[32]   Primary Graft Dysfunction in Lung Transplantation: An Overview of the Molecular Mechanisms [J].
Jennekens, Jitte ;
Braithwaite, Sue A. ;
Luijk, Bart ;
van der Kaaij, Niels P. ;
Vrisekoop, Nienke ;
de Jager, Saskia C. A. ;
de Heer, Linda M. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (14)
[33]   PURIFICATION OF BOVINE HISTIDINE-RICH GLYCOPROTEIN [J].
MULDBJERG, M ;
SCHOUSBOE, I ;
HALKIER, T .
THROMBOSIS RESEARCH, 1992, 65 (06) :815-819
[34]   Lung Ultrasound as a Promising Diagnostic Tool for Primary Graft Dysfunction after Lung Transplantation [J].
Schroeder, Ines ;
Scharf, Christina ;
Schneider, Julia ;
Weggesser, Patricia ;
Huebner, Lucas ;
Kneidinger, Nikolaus ;
Michel, Sebastian ;
Schneider, Christian ;
Clevert, Dirk-Andre ;
Sabel, Bastian ;
Irlbeck, Michael ;
Scheiermann, Patrick .
ULTRASCHALL IN DER MEDIZIN, 2023, 44 (05) :537-543
[35]   Center volume and primary graft dysfunction in patients undergoing lung transplantation in the United States - a cohort study [J].
Jawitz, Oliver K. ;
Raman, Vignesh ;
Bryner, Benjamin S. ;
Klapper, Jacob ;
Hartwig, Matthew G. .
TRANSPLANT INTERNATIONAL, 2021, 34 (01) :194-203
[36]   Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation [J].
Shah, Rupal J. ;
Diamond, Joshua M. ;
Lederer, David J. ;
Arcasoy, Selim M. ;
Cantu, Edward M. ;
Demissie, E. J. ;
Kawut, Steven M. ;
Kohl, Benjamin ;
Lee, James C. ;
Sonett, Joshua ;
Christie, Jason D. ;
Ware, Lorraine B. .
TRANSLATIONAL RESEARCH, 2012, 160 (06) :435-442
[37]   How Would You Grade Our Progress in Primary Graft Dysfunction after Lung Transplantation? [J].
Neyrink, Arne ;
Verleden, Geert M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (02) :155-157
[38]   Atelectasis in primary graft dysfunction survivors after lung transplantation [J].
Li, David ;
Abele, Jonathan ;
Weinkauf, Justin ;
Kapasi, Ali ;
Hirji, Alim ;
Varughese, Rhea ;
Nagendran, Jayan ;
Lien, Dale ;
Doucette, Karen ;
Halloran, Kieran .
CLINICAL TRANSPLANTATION, 2021, 35 (07)
[39]   The effect of primary graft dysfunction on survival after lung transplantation [J].
Christie, JD ;
Kotloff, RM ;
Ahya, VN ;
Tino, G ;
Pochettino, A ;
Gaughan, C ;
DeMissie, E ;
Kimmel, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (11) :1312-1316
[40]   Development and validation of a nomogram model to predict primary graft dysfunction in patients after lung transplantation based on the clinical factors [J].
Qin, Jianan ;
Hu, Chunxiao ;
Cao, Xiaodong ;
Gao, Jian ;
Chen, Yuan ;
Yan, Meiqiong ;
Chen, Jingyu .
CLINICAL TRANSPLANTATION, 2023, 37 (10)